Mouse study identifies bile acid pathways that may reduce liver fat

Дата публикации: 17-09-2026 13:20:16

Nonalcoholic fatty liver disease (NAFLD), now known as metabolic dysfunction-associated steatotic liver disease (MASLD), is a common condition that causes excess fat to build up in the liver, affecting about one-quarter of adults worldwide. In some people, this can lead to inflammation and hepatocyte injury, triggering the formation of thick, fibrous connective tissue known as fibrosis.

Основное содержимое страницы с новостью.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Why some adults under 50 may develop early-onset cirrhosis from fatty liver disease	0	13.37	16-09-2026
2	Experimental drug reverses severe fatty liver disease by repairing the gut	0	5	11-07-2026
3	MASH Comorbidity Burden and Overall, Waiting List, and Post–Liver Transplant Mortality	0	8.64	05-08-2026
4	Metabolic improvements cut MASLD-linked colorectal neoplasia risk	0	12.12	12-08-2026
5	Найдено природное вещество против жировой болезни печени	0	10	28-08-2026
6	Lipid Accumulation Product Correlates with Metabolic Dysfunction- Associated Steatohepatitis: Implications for Hepatic Steatosis in Patients with Obesity	0	13.31	20-08-2026
7	Рейтинг ТОП 5 лучших препаратов для печени – Рейтинг 2026 года	0	11.86	13-11-2018
8	The EMBO Journal: CNIC researchers identify a protein essential for preventing liver damage and tumor development during aging	0	7.34	05-08-2026
9	The effect of high-intensity interval training and vitamin D3 supplementation on fructose-induced liver inflammation in male Sprague-Dawley rats	0	5	15-07-2026
10	Врач назвала простую привычку для снижения риска жировой болезни печени	0	5.8	12-08-2026

Классификация: . Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 9.19. Источник: medicalxpress.com.